NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 323 filers reported holding NATERA INC in Q1 2023. The put-call ratio across all filers is 0.49 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $15,207,920 | -41.1% | 378,589 | -35.7% | 1.62% | -56.2% |
Q3 2022 | $25,805,000 | +23.6% | 588,886 | 0.0% | 3.70% | +39.6% |
Q2 2022 | $20,870,000 | -12.9% | 588,886 | 0.0% | 2.65% | +38.2% |
Q1 2022 | $23,956,000 | -56.4% | 588,886 | 0.0% | 1.92% | -53.6% |
Q4 2021 | $54,996,000 | -16.2% | 588,886 | 0.0% | 4.13% | -10.6% |
Q3 2021 | $65,625,000 | -1.8% | 588,886 | 0.0% | 4.62% | +4.0% |
Q2 2021 | $66,856,000 | +24.9% | 588,886 | +11.7% | 4.44% | +33.6% |
Q1 2021 | $53,520,000 | +42.0% | 527,086 | +39.2% | 3.32% | +21.9% |
Q4 2020 | $37,677,000 | +37.8% | 378,589 | 0.0% | 2.73% | -2.4% |
Q3 2020 | $27,349,000 | -27.6% | 378,589 | -50.0% | 2.79% | +51.7% |
Q2 2020 | $37,752,000 | +233.9% | 757,178 | +100.0% | 1.84% | +28.7% |
Q1 2020 | $11,305,000 | -55.7% | 378,589 | -50.0% | 1.43% | +26.1% |
Q4 2019 | $25,510,000 | +105.4% | 757,178 | +100.0% | 1.14% | +20.9% |
Q3 2019 | $12,418,000 | -40.5% | 378,589 | -50.0% | 0.94% | -6.7% |
Q2 2019 | $20,882,000 | – | 757,178 | – | 1.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blue Water Life Science Advisors, LP | 1,104,581 | $48,403,000 | 19.54% |
Kynam Capital Management, LP | 2,018,360 | $88,445,000 | 18.64% |
Foresite Capital Management III, LLC | 159,160 | $6,974,000 | 18.41% |
Sofinnova Investments, Inc. | 3,102,960 | $135,972,000 | 7.91% |
Eagle Health Investments LP | 595,994 | $26,116,000 | 5.99% |
Eversept Partners, LP | 1,425,602 | $62,469,880 | 5.41% |
Lagoda Investment Management, L.P. | 159,220 | $6,977,000 | 4.96% |
Hudson Executive Capital LP | 588,886 | $25,805,000 | 3.70% |
Parian Global Management LP | 24,000 | $1,052,000 | 3.42% |
BRANDYWINE MANAGERS, LLC | 21,534 | $944,000 | 3.10% |